Concepedia

Thomas Dvorak

TD

5

Publications

219

Citations

5

H-Index

2013

Active since

Affiliations

Baxter (Austria)(Current)

Medical University of Vienna

University of Applied Sciences Mainz

University of Tübingen

Baxter (United States)

Thomas Dvorak is an author at Baxter (Austria) specializing in vaccine safety, vaccine development, and parasitology.

Top concepts

Publications per year

2013–2016

5

Publications

5

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger et al. · The Lancet Infectious Diseases · 2013 · 100 citations

, , +9

A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Nina Wressnigg, Perry Barrett, Eva-Maria Pöllabauer et al. · Clinical and Vaccine Immunology · 2014 · 46 citations · Full text

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population

Maikel V. W. van der Velden, Richard Fritz, Daniel Portsmouth et al. · The Journal of Infectious Diseases · 2013 · 32 citations · Full text

Efficacy and safety of pegylated full‐length recombinant factor <scp>VIII</scp> with extended half‐life for perioperative haemostasis in haemophilia A patients

B. Brand, Ralph A. Gruppo, Tung Wynn et al. · Haemophilia · 2016 · 28 citations · Full text

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients

Maikel V. W. van der Velden, Alexander Geisberger, Thomas Dvorak et al. · Clinical and Vaccine Immunology · 2014 · 13 citations · Full text

Rows per page

1–5 of 5